A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Tiral in Healthy Male Volunteers

NCT06736587 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: DWP212525 10mg
DRUG: DWP212525 30mg
DRUG: DWP212525 50mg
DRUG: DWP212525 100mg
DRUG: DWP212525 200mg
DRUG: DWP212525 400mg
DRUG: DWP212525 placebo

Sponsor

Daewoong Pharmaceutical Co. LTD.